Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 12 holding rows worth $108,875,486.

Accession
0000950123-23-010476
Filed
2023-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 12 entries on the cover page, a total value of $108,875,486 stated on the cover page (in dollars after the unit check, H1), rows summing to $108,875,488 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REPLIMUNE GROUP INC76029N106COMMON STOCK3,001,319$51,352,568dollars as filed
NUVATION BIO INC COM CL A67080N101Stock15,072,340$20,196,936dollars as filed
IKENA ONCOLOGY INC45175G108COM2,249,123$9,738,703dollars as filed
MORPHIC HLDG INC61775R105COM309,846$7,098,572dollars as filed
KRONOS BIO INC50107A104COM3,818,283$4,963,768dollars as filed
SPRUCE BIOSCIENCES INC85209E109COM2,161,022$4,883,910dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$3,265,313dollars as filed
IMMUNIC INC4525EP101COM1,788,160$2,628,595dollars as filed
THESEUS PHARMACEUTICALS INC88369M101COM711,479$1,913,879dollars as filed
ALPINE IMMUNE SCIENCES INC02083G100COM153,700$1,759,865dollars as filed
SYROS PHARMACEUTICALS INC87184Q206COM NEW251,270$992,517dollars as filed
Senti Biosciences, Inc.81726A100Common Stock195,792$80,862dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-010476this filing2023-11-14acceptance time not in the bulk data set